Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PRASUGREL HYDROCHLORIDE USP, with a corresponding US DMF Number 25651.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 24, 2013, and payment made on June 03, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II